Clinical Trials Logo

Citation(s)

Secondary Prophylaxis Use of Romiplostim for the Prevention of Thrombocytopenia Induced by Temozolomide in Newly Diagnosed Glioblastoma Patients

Details for clinical trial NCT02227576